GlassScriptPhysician profile
Lisa I Keithley
NPI 1760459887
$3,660.01
in general payments reported to CMS, 2019-2025
39 companies · $376 in 2025
The $376 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $130 · 2020: $535 · 2021: $926 · 2022: $750 · 2023: $769 · 2024: $173 · 2025: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,317.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $720.60 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $717.87 | 2021-2025 | |
| Pfizer INC. | $333.43 | 2019-2025 | |
| Glaxosmithkline, LLC. | $188.36 | 2019-2023 | Arexvy, Shingrix |
| Amgen INC. | $149.68 | 2019-2025 | Krystexxa |
| Amarin Pharma, INC. | $141.75 | 2020-2021 | |
| Lilly USA, LLC | $133.80 | 2019-2024 | Mounjaro, Zepbound, Trulicity |
| Allergan, INC. | $133.54 | 2019-2020 | |
| Esperion Therapeutics, INC. | $116.88 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $116.78 | 2020-2025 | Airsupra |
| Globus Medical, INC. | $83.62 | 2025 | Senza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.49 | 2020-2024 | Jardiance |
| Corium, LLC | $65.37 | 2023 | Azstarys |
| Jazz Pharmaceuticals INC. | $55.73 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.97 | 2021-2023 | Xifaxan, Trulance |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Keithley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.